Asia Pacific Proteomics Market Size, Growth, Share & Trends Analysis
Asia Pacific Proteomics Market by Instrumentation [Mass Spectrometry, HPLC, Electrophoresis, Protein Microarray], Reagent (Immunoassay), Service (Purification, Bioinformatics), Software, Application (Clinical, Drug Discovery) - Global Forecast to 2030
OVERVIEW
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The Asia Pacific Proteomics Market, valued at US$7.82 billion in 2024, stood at US$8.57 billion in 2025 and is projected to advance at a resilient CAGR of 14.1% from 2025 to 2030, culminating in a forecasted valuation of US$16.61 billion by the end of the period., supported by rapid advances in mass spectrometry, bioinformatics, and high-throughput sample-processing platforms. Proteomics focuses on measuring dynamic protein expression, modifications, and interactions at scale, enabling deeper insights into disease biology and treatment response for oncology, neurology, and other complex indications.
KEY TAKEAWAYS
-
BY COUNTRYIn the Asia Pacific region, the proteomics market in China is projected to register the highest CAGR of 15% during the forecast period.
-
BY INTRUMENTATION TECHNOLOGYBy product, the spectroscopy segment is expected to dominate the market during the forecast period.
-
BY REAGENTBy reagent, the immunoassay reagent segment is projected to grow at the highest rate from 2025 to 2030.
-
BY SERVICEBy service, the core proteomics services segment is expected to lead the market during the forecast period.
-
BY SOFTWAREBy software, the bioinformatics tools segment is expected to dominate the market during the forecast period.
-
BY APPLICATIONBy application, the clinical diagnostics segment is projected to grow at the highest rate during the forecast period.
-
BY END USERBy end user, the biopharmaceutical companies segment is expected to lead the market during the forecast period.
-
COMPETITIVE LANDSCAPEThermofisher Scientific Inc (US), Danaher Corporation (US), and Agilent Technologies (US) were identified as some of the star players in the market, given their strong market share and product footprint.
-
COMPETITIVE LANDSCAPESeer Inc. (US) and MedGenome (India), among others, have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders.
The Asia Pacific proteomics market is growing steadily, with vast investment in the biopharma sector, development of healthcare infrastructure, as well as an escalation in proteomics adoption in precision medicine. Proteomics platforms assist scientists in understanding disease pathways and developing new medications, thus enabling targeted therapies in the areas of cancer, neurological disorders, and chronic diseases.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
The Asia Pacific proteomics market is undergoing a paradigm shift due to the increasing pace of biomedical research intensity, an extended pharma pipeline, and government support for precise medicine initiatives, and this scenario is likely to continue throughout the forecast period. The increasing use of proteomics in the study of oncology, infectious diseases, metabolic disorders, and large-scale health research across Asia, especially in China, Japan, South Korea, and India, is a key factor driving the demand for proteomics solutions and platforms. The rising numbers of clinical trials and biopharmaceutical manufacturing in the APAC region are driving the use of optimized proteomics workflows that are amenable to automation and provide precise proteomics data.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
Level
-
Strong government funding for precision medicine, cancer research, and population-scale health initiatives
-
Rising adoption of mass spectrometry-based and immunoassay-based proteomics in academic and hospital research labs
Level
-
Shortage of skilled proteomics and bioinformatics professionals in emerging APAC markets
Level
-
Expansion of local manufacturing and regional service centers by global proteomics vendors
Level
-
Bridging gap between research-use proteomics and routine clinical adoption
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Driver:Strong government funding for precision medicine, cancer research, and population-scale health initiatives
Strong government funding across China, Japan, South Korea, and Australia is accelerating proteomics adoption in precision medicine, cancer research, and large-scale population health programs, supporting expanded research infrastructure and technology deployment.
Restraint: Shortage of skilled proteomics and bioinformatics professionals in emerging APAC markets
A shortage of trained proteomics scientists and bioinformatics professionals in several emerging APAC markets limits advanced data analysis capabilities and slows broader adoption of complex proteomics workflows.
Opportunity: Expansion of local manufacturing and regional service centers by global proteomics vendors
Global proteomics vendors are expanding local manufacturing, application labs, and regional service centers across APAC, improving technology accessibility, reducing turnaround times, and supporting faster market penetration.
Challenge: Bridging the gap between research-use proteomics and routine clinical adoption
Bridging the gap between research-use proteomics and routine clinical implementation remains challenging due to regulatory variability, validation requirements, and the need for standardized, clinically robust workflows.
ASIA PACIFIC PROTEOMICS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
LCMS-9050 Q-TOF and Nexera UHPLC systems enable high-resolution proteomics workflows for Japanese/Chinese CROs and academic labs focused on biomarker discovery in oncology and neurodegeneration ? | Delivers ultra-sensitive protein ID/quantitation with AI-driven data processing for regulatory-grade APAC clinical trials ? |
 |
Integrated LC-MS/multiomics platforms support precision medicine R&D, including proteomics for drug target validation and companion diagnostics in India's booming biopharma sector ? | Provides scalable, CAP-accredited proteomics data packages tailored for South Asian population |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
The Asia Pacific proteomics market integrates instrument providers, bioinformatics providers, contract research organizations, and research-oriented companies. They provide the infrastructure necessary for hospitals and pharmaceutical companies in China, India, and Japan to quickly discover biomarkers and provide quality outputs for the better implementation of precision medicine through proteomics.
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
APAC Proteomics Market, by Instrumentation Technology
In 2024, mass spectroscopy platforms dominate the APAC proteomics market as China and Japan's research/clinical labs prioritize deep protein ID/quantification for oncology and neurodegeneration studies.
APAC Proteomics Market, by Reagent
In 2024, the immunoassay reagents segment accounted for the largest market share, driven by demand for biomarker validation in drug development and clinical studies.
APAC Proteomics Market, by Service
Core proteomics services dominate the market. Many pharma companies and hospitals outsource complex LC-MS/multiomics workflows to specialized APAC CROs/core facilities for faster, high-quality data generation
APAC Proteomics Market, By Software
In 2024, bioinformatics tools/software held the major market share. Advanced data analysis, visualization, and integration platforms connect proteomics data with genomic/clinical information.
APAC Proteomics Market, By Application
By application, the clinical diagnostics segment is expected to witness the fastest growth, driven by China's National Precision Medicine Initiative and Japan's 100,000 Genomes Project integrating proteomics for TB/cancer biomarkers. Singapore's A*STAR labs deploy multiplexed assays for real-time therapy monitoring in hepatocellular carcinoma.
APAC Proteomics Market, By End User
Biopharmaceutical companies were the leading end-user group in 2024. These companies leverage LC-MS proteomics for biosimilar development and ADC payload optimization. India's Biocon/Biocon-Glenmark uses proteomics for optimizing monoclonal antibody production yields and glycosylation profiling.
REGION
China to be fastest-growing country in Asia Pacific Proteomics market during forecast period
China is expected to be the fastest-growing market for proteomics in the Asia Pacific region, driven by substantial government investments in precision medicine initiatives, which are bolstering the development of the biological pharmaceuticals and CRO infrastructure. Additionally, the large population provides ample opportunities for clinical research, and there is an increasing adoption of high-throughput proteomics platforms among research institutes and pharmaceutical companies.
ASIA PACIFIC PROTEOMICS MARKET: COMPANY EVALUATION MATRIX
In the APAC proteomics market matrix, Thermo Fisher leads the market due to extensive regional adoption of LC-MS platforms, broad reagent and consumable supply, strong service infrastructure, and integration of high-throughput workflows across pharma, CROs, hospitals, and academic labs. Shimadzu Corporation is an emerging leader with a strong installed presence in Japan and growing traction in China, India, and Southeast Asia, driven by reliable mass spectrometry and proteomics instruments tailored to regional research and clinical labs
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
- Thermo Fisher Scientific Inc. (US)
- Danaher Corporation (US)
- Agilent Technologies (US)
- Brukers Corporation (US)
- Shimadzu Corporation (Japan)
- Bio-Rad Laboratories (US)
- Waters Corporation (US)
- Qiagen (Netherlands)
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size in 2024 (Value) | USD 7.82 Billion |
| Market Forecast in 2030 (Value) | USD 16.61 Billion |
| Growth Rate | CAGR of 14.1% from 2025 to 2030 |
| Years Considered | 2023-2030 |
| Base Year | 2024 |
| Forecast Period | 2025-2030 |
| Units Considered | Value (USD Million) |
| Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments Covered |
|
| Countries Covered | China, Japan, India, Australia, South Korea, Rest of Asia Pacific |
WHAT IS IN IT FOR YOU: ASIA PACIFIC PROTEOMICS MARKET REPORT CONTENT GUIDE
DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| Proteomics market landscape and adoption drivers (Asia Pacific) | Evaluated proteomics technology adoption across major APAC countries by funding intensity, institutional maturity, and clinical research activity, highlighting differences between established markets (Japan, Australia, South Korea) and high-growth markets (China, India). Assessed vendor competitiveness based on localization strategies, pricing flexibility, service infrastructure, and workflow standardization. | Enables technology providers to align product design, pricing, and service models with heterogeneous APAC customer requirements, improving penetration beyond top-tier research institutes into broader hospital and CRO networks. |
| Platform evolution and translational readiness across Asia Pacific research ecosystems | Analyzed the role of national genomics and population-health initiatives in accelerating proteomics uptake, with case examples from cancer, infectious disease, and metabolic disorder programs. Tracked the movement of proteomics from discovery labs into CRO-led translational studies and early clinical validation pipelines. | Supports strategic planning by identifying country-level inflection points, partnership opportunities, and investment hotspots where proteomics demand is expected to scale fastest, helping stakeholders allocate resources effectively across the diverse APAC market landscape. |
RECENT DEVELOPMENTS
- May 2024 : Shimadzu Corporation launched the LCMS-8060RX, LCMS-8050RX, and LCMS-8045RX triple quadrupole high-performance liquid chromatograph mass spectrometers, designed to deliver more reliable data through enhanced high sensitivity and stability while boosting laboratory efficiency with automatic calibration.
- October 2023 : Shimadzu Corporation began the full-scale production and shipment of high-end mass spectrometers (MS) in China to meet the increased demand for LC-MS and GC-MS for clinical applications.
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
Methodology
This study involved four major activities in estimating the current size of the asia pacific proteomics market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. The top-down and other approaches were employed to estimate the complete market size (asia pacific proteomics market size). After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the asia pacific proteomics market. The secondary sources referred to for this research study include publications from government and private sources such as the Indian Pharmaceutical Association (IPA), the Pharmaceutical Research and Manufacturers of America (PhRMA), the European Federation of Pharmaceutical Industries and Associations (EFPIA), Central Drugs Standard Control Organization (CDSCO), Indian Brand Equity Foundation (IBEF), European Medicines Agency (EMA), Global Cancer Observatory (GCO), American Chemical Society (ACS), National Center for Biotechnology Information (NCBI), Food and Drug Administration (FDA), Biotechnology and Biological Sciences Research Council (BBSRC), Pharmaceutical Research and Manufacturers of America (PhRMA), and the World Journal of Pharmaceutical Sciences, Company Websites, Annual Reports, SEC Filings, Press Releases, Investor Presentations, Journals, Expert Interviews, MarketsandMarkets Analysis. Secondary data was collected and analyzed to arrive at the overall size of the global asia pacific proteomics market, which was then validated by primary research.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Asia Pacific Proteomics Market Size Estimation
A top-down approach was used to estimate and validate the total size of the asia pacific proteomics market. This method was also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the total asia pacific proteomics market size includes the following:
Data Triangulation
After arriving at the overall asia pacific proteomics market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Asia Pacific Proteomics is the complete evaluation of the structure and function of proteins to understand an organism’s nature. It is the systemic identification and characterization of proteins along with their sequence, abundance, post-translational modifications, interactions, activity, subcellular localization, and structure. The market study includes the assessment of various instruments, reagents, software, and services used in asia pacific proteomics.
Key Stakeholders
- Life sciences instrumentation and reagent companies
- Pharmaceutical and biotechnology companies
- Asia Pacific Proteomics database and software providers
- Asia Pacific Proteomics service providers
- Research and consulting firms
- Academic medical centers
- Government research organizations
- Clinical research institutes
- Contract Research Organizations
Report Objectives
- To define, describe, and forecast the global asia pacific proteomics market based on the instrumentation technologies, reagents, software & services, application, end-user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, challenges, and opportunities)
- To strategically analyze micro markets with respect to individual growth trends, future prospects, and contributions to the overall asia pacific proteomics market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
- To strategically profile the key players and comprehensively analyze their product & service portfolios, market positions, and core competencies
- To track and analyze competitive developments such as product launches, acquisitions, expansions, agreements, collaborations, and R&D activities in the asia pacific proteomics market.
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:
Geographic Analysis
- Further breakdown of the Rest of Europe asia pacific proteomics market into respective countries
- Further breakdown of the Rest of Asia Pacific asia pacific proteomics market into respective countries
- Further breakdown of the Rest of Latin America asia pacific proteomics market into respective countries
Company Information
- Detailed analysis and profiling of additional market players (Up to 5)
- An additional five company profiles
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This ReportPersonalize This Research
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
Let Us Help You
- What are the Known and Unknown Adjacencies Impacting the Asia Pacific Proteomics Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Custom Market Research Services
We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements
Get 10% Free Customisation
Growth opportunities and latent adjacency in Asia Pacific Proteomics Market